A Facile Synthesis and Molecular Characterization of Certain New Anti-Proliferative Indole-Based Chemical Entities
Reem I Al-Wabli1, Iman S Issa1, Maha S Al-Mutairi1
1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Abstract:
Cancer cells frequently develop drug resistance, which leads to chemotherapeutic treatment failure. Additionally, chemotherapies are hindered by their high toxicity. Therefore, the development of new chemotherapeutic drugs with improved clinical outcomes and low toxicity is a major priority. Several indole derivatives exhibit distinctive anti-cancer mechanisms which have been associated with various molecular targets. In this study, target compounds 4a-q were obtained through the reaction of substituted benzyl chloride with hydrazine hydrate, which produces benzyl hydrazine. Subsequently, the appropriate substituted benzyl hydrazine was allowed to react with 1H-indole-2-carboxylic acid or 5-methoxy-1H-indole-2-carboxylic acid using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as a coupling agent. All compounds exhibited cytotoxicity in three cell lines, namely, MCF-7, A549, and HCT. Compound 4e exhibited the highest cytotoxicity, with an average IC50 of 2 µM. Moreover, a flow cytometry study revealed a significantly increased prevalence of Annexin-V and 7-AAD positive cell populations. Several derivatives of 4a-q showed moderate to high cytotoxicity against the tested cell lines, with compound 4e having the highest cytotoxicity, indicating that it may possess potential apoptosis-inducing capabilities.
Insights
Researchers developed novel indole derivatives as potential anti-cancer drugs. Compound 4e demonstrated significant cytotoxicity, suggesting it may induce apoptosis and overcome drug resistance in cancer cells.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Chemotherapy faces challenges due to drug resistance and high toxicity.
- Indole derivatives are known for diverse anti-cancer mechanisms and molecular targets.
Purpose of the Study:
- To synthesize and evaluate novel indole derivatives for anti-cancer activity.
- To identify potent compounds with reduced toxicity compared to conventional chemotherapies.
Main Methods:
- Synthesis of indole derivatives (compounds 4a-q) via benzyl hydrazine and indole-2-carboxylic acid coupling.
- Cytotoxicity assessment using MCF-7, A549, and HCT cancer cell lines.
- Flow cytometry analysis to investigate apoptosis induction (Annexin-V and 7-AAD staining).
Main Results:
- All synthesized compounds (4a-q) displayed cytotoxicity against tested cell lines.
- Compound 4e exhibited the highest cytotoxicity with an IC50 of 2 µM.
- Flow cytometry confirmed increased apoptosis markers in treated cells.
Conclusions:
- Indole derivatives, particularly compound 4e, show promising anti-cancer potential.
- Compound 4e may induce apoptosis, offering a strategy to overcome cancer drug resistance.
- Further research into these compounds could lead to improved cancer therapeutics.
